Form D · Biotechnology
AgeneBio, Inc.
Baltimore, MD · CIK 0001467758
Offering snapshot reported Jul 28, 2016 · SEC filing
- Reported sold
- $500K Offering amount: $3M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 26, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 28, 2016 | Initial | $500,076 | No comparison | 5 | SEC filing |
| Feb 6, 2015 | Initial | $400,000 | No comparison | 1 | SEC filing |
| Oct 17, 2014 | Initial | $4,113,127 | No comparison | 15 | SEC filing |
| Nov 18, 2013 | Initial | $1,000,113 | No comparison | 2 | SEC filing |
| Jun 4, 2013 | Initial | $1,000,000 | No comparison | 6 | SEC filing |
| Sep 25, 2012 | Initial | $450,000 | No comparison | 6 | SEC filing |
| Dec 22, 2011 | Amendment | $3,688,610 | $2,292,000vs May 19, 2011 | 27 | SEC filing |
| May 19, 2011 | Amendment | $1,396,610 | $550,000vs Jan 7, 2011 | 11 | SEC filing |
| Jan 7, 2011 | Amendment | $846,610 | $736,457vs Oct 5, 2010 | 7 | SEC filing |
| Oct 5, 2010 | Initial | $110,153 | No comparison | 1 | SEC filing |
| Apr 12, 2010 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Jul 10, 2009 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-267885
Source: Form D, filed Jul 28, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Barrett | Director |
| Floyd Bloom | Director |
| Charles Clarvit | Director |
| Michela Gallagher | Director |
| Patrick Lepore | Director |
| Gerald W. Mclaughlin | Director, Executive |
| Ronald Nordmann | Director |
| Timothy F. Parshall | Director, Executive |
| Robert Postlethwait | Director, Executive |
| William Ringo | Director |
| Sharon Rosenzweig Lipson | Executive |
| Kristin Sherman | Executive |
| Gardiner Smith | Director, Executive |
| Brian Stemme | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1101 E. 33rd Street, Suite C310
Baltimore, MD, 21218
Baltimore, MD, 21218